PACB vs. SPY
Compare and contrast key facts about Pacific Biosciences of California, Inc. (PACB) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PACB or SPY.
Performance
PACB vs. SPY - Performance Comparison
Returns By Period
In the year-to-date period, PACB achieves a -84.00% return, which is significantly lower than SPY's 24.91% return. Over the past 10 years, PACB has underperformed SPY with an annualized return of -13.73%, while SPY has yielded a comparatively higher 13.04% annualized return.
PACB
-84.00%
-20.71%
-18.23%
-81.31%
-21.39%
-13.73%
SPY
24.91%
0.61%
11.66%
32.24%
15.43%
13.04%
Key characteristics
| PACB | SPY | |
|---|---|---|
| Sharpe Ratio | -0.68 | 2.67 |
| Sortino Ratio | -0.98 | 3.56 |
| Omega Ratio | 0.88 | 1.50 |
| Calmar Ratio | -0.81 | 3.85 |
| Martin Ratio | -1.14 | 17.38 |
| Ulcer Index | 69.69% | 1.86% |
| Daily Std Dev | 116.57% | 12.17% |
| Max Drawdown | -97.65% | -55.19% |
| Current Drawdown | -96.93% | -1.77% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between PACB and SPY is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
PACB vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Pacific Biosciences of California, Inc. (PACB) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PACB vs. SPY - Dividend Comparison
PACB has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.19%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PACB Pacific Biosciences of California, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.19% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% | 1.81% |
Drawdowns
PACB vs. SPY - Drawdown Comparison
The maximum PACB drawdown since its inception was -97.65%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for PACB and SPY. For additional features, visit the drawdowns tool.
Volatility
PACB vs. SPY - Volatility Comparison
Pacific Biosciences of California, Inc. (PACB) has a higher volatility of 32.98% compared to SPDR S&P 500 ETF (SPY) at 4.08%. This indicates that PACB's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.